Common Contracts
1 similar Asset Purchase Agreement contracts
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • July 28th, 2023 • Delaware
This Asset Purchase Agreement (this “Agreement”) is entered into as of July 28, 2023 by and among Vyera Pharmaceuticals, LLC, a Delaware limited liability company (“Vyera”), Phoenixus AG, a Swiss corporation (“Phoenixus”), and Tilde Sciences LLC, a Delaware limited liability company (the “Buyer”). Phoenixus and Vyera are each referred to in this Agreement as a “Seller” or “Debtor” (as applicable) and collectively referred to herein as the “Sellers” or “Debtors”. Sellers and Buyer are collectively referred to in this Agreement as the “Parties” and individually as a “Party”. Oakrum Pharma, LLC, SevenScore Pharmaceuticals, LLC, Dermelix Biotherapeutics, LLC, and Orpha Labs AG (collectively, the “Additional Debtor Parties”) join this Agreement for the limited purpose set forth in Section 7.10. For purposes of this Agreement, capitalized terms used herein shall have the meanings set forth herein or in Article IX.
